ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,293Medicare Part D Prescriptions Filled, Including Refills

Rank: 305 out of 783

$397K Total Retail Price of All Prescriptions

Rank: 364 out of 783

529 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 4,448 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 511 267 S3 1 2
OMEPRAZOLE 222 165 2 6
LISINOPRIL 198 137 3 4
TRAMADOL HCL 177 90 4 20
FUROSEMIDE 170 137 5 7
LEVOTHYROXINE SODIUM 169 126 6 1
METFORMIN HCL 150 51 7 8
SIMVASTATIN 133 74 8 3
MELOXICAM 130 70 9 37
AMLODIPINE BESYLATE 125 95 10 5
GABAPENTIN 119 68 11 15
WARFARIN SODIUM 119 90 11 10
HYDROCHLOROTHIAZIDE 110 98 13 12
ATORVASTATIN CALCIUM 103 76 14 11
PRAVASTATIN SODIUM 98 56 15 14
METOPROLOL TARTRATE 93 66 16 9
SERTRALINE HCL 90 70 17 22
ZOLPIDEM TARTRATE 89 51 18 23
ATENOLOL 85 62 19 17
CYCLOBENZAPRINE HCL 84 33 R 20 63
GLIMEPIRIDE 80 39 21 34
CITALOPRAM HBR 77 32 22 19
FLUOXETINE HCL 76 52 23 45
PANTOPRAZOLE SODIUM 71 37 24 30
POTASSIUM CHLORIDE 69 63 25 16
LOVASTATIN 69 44 25 58
CLOPIDOGREL 68 51 27 29
NEXIUM 67 42 28 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 29 28 33
CIPROFLOXACIN HCL 65 46 30 62
LYRICA 64 11 31 98
CRESTOR 63 45 32 27
LANTUS 61 34 33 38
TRAZODONE HCL 54 34 34 39
METOPROLOL SUCCINATE 54 52 34 13
ALENDRONATE SODIUM 52 47 36 25
AZITHROMYCIN 51 40 37 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.